Study of Anlotinib Hydrochloride Capsules in the Treatment of Locally Advanced or Metastatic Radioiodine-Refractory Differentiated Thyroid Carcinoma
Clinical trial NCT05994365 · RECRUITING
Trial details
- NCT number
- NCT05994365
- Sponsor
- Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
- Status
- RECRUITING
- Study type
- OBSERVATIONAL
- Start date
- 2023-08-01
- Primary completion
- 2027-08-01
- Enrollment
- 380
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.